Table 3 The ongoing clinical trials on R428 in cancers
From: Molecular insights of Gas6/TAM in cancer development and therapy
Identifiers | Start date | Cancers | Time frame | Phase | Status |
|---|---|---|---|---|---|
NCT02922777 | November 2016 | Non-small cell lung carcinoma | 42 days | Phase 1 | Recruiting |
NCT02488408 | September 2014 | Acute myeloid leukaemia | 15 months | Phase 1 | Recruiting |
NCT02424617 | March 2015 | Non-small cell lung cancer | 3 months | Phase 1/2 | Recruiting |
NCT02872259 | September 2016 | Melanoma | An average of 1 year | Phase 1/2 | Not yet recruiting |
